Published in Ann Neurol on May 01, 2002
Parkinson's disease in GTP cyclohydrolase 1 mutation carriers. Brain (2014) 5.12
Protein kinase A-dependent recruitment of RNA polymerase II, C/EBP beta and NF-Y to the rat GTP cyclohydrolase I proximal promoter occurs without alterations in histone acetylation. J Neurochem (2007) 0.88
Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan disease. Ann Neurol (2014) 0.78
Clinical spectrum of dopa-responsive dystonia and related disorders. Curr Neurol Neurosci Rep (2014) 0.77
Sister grouping of chimpanzees and humans as revealed by genome-wide phylogenetic analysis of brain gene expression profiles. Proc Natl Acad Sci U S A (2004) 2.74
Current concepts in the diagnosis and management of Parkinson's disease. CMAJ (2003) 1.83
Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin. J Neurochem (2004) 1.82
Mining Affymetrix microarray data for long non-coding RNAs: altered expression in the nucleus accumbens of heroin abusers. J Neurochem (2010) 1.67
Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation (2003) 1.65
Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. J Neurosci (2012) 1.48
Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse. Neuropsychopharmacology (2006) 1.45
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain (2009) 1.44
Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms. Mov Disord (2012) 1.44
Culture of skin cells in 3D rather than 2D improves their ability to survive exposure to cytotoxic agents. J Biotechnol (2006) 1.43
Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys (2005) 1.42
Next generation nerve guides: materials, fabrication, growth factors, and cell delivery. Tissue Eng Part B Rev (2011) 1.41
Mitochondria in Alzheimer's disease. Int Rev Neurobiol (2002) 1.40
Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine. Eur J Pharmacol (2002) 1.30
Why is parkinsonism not a feature of human methamphetamine users? Brain (2003) 1.29
Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. J Neurochem (2003) 1.28
Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug Alcohol Depend (2011) 1.25
Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity. J Med Chem (2005) 1.22
Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders. Mov Disord (2010) 1.20
Development of biodegradable electrospun scaffolds for dermal replacement. Biomaterials (2008) 1.19
Genotypic and phenotypic characterization of methicillin-susceptible Staphylococcus aureus isolates misidentified as methicillin-resistant Staphylococcus aureus by the BD GeneOhm MRSA assay. J Clin Microbiol (2011) 1.17
Time-resolved and two-photon emission imaging microscopy of live cells with inert platinum complexes. Proc Natl Acad Sci U S A (2008) 1.17
Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol Cancer Ther (2004) 1.16
The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Addiction (2013) 1.15
Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker? J Neurosci (2008) 1.12
Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies. J Cereb Blood Flow Metab (2013) 1.12
Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1. J Immunol (2005) 1.11
Methamphetamine use and schizophrenia: a population-based cohort study in California. Am J Psychiatry (2012) 1.09
Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine. J Pharmacol Exp Ther (2006) 1.07
The promoter for the gene encoding the catalytic subunit of rat glucose-6-phosphatase contains two distinct glucose-responsive regions. Am J Physiol Endocrinol Metab (2006) 1.07
Gene expression profiling in the brains of human cocaine abusers. Addict Biol (2005) 1.07
Activity-dependent phosphorylation of tyrosine hydroxylase in dopaminergic neurons of the rat retina. J Neurosci (2004) 1.06
c-Myc and ChREBP regulate glucose-mediated expression of the L-type pyruvate kinase gene in INS-1-derived 832/13 cells. Am J Physiol Endocrinol Metab (2007) 1.05
Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra. J Neurochem (2004) 1.05
Brain vesicular acetylcholine transporter in human users of drugs of abuse. Synapse (2004) 1.05
Development of a 3D cell culture system for investigating cell interactions with electrospun fibers. Biotechnol Bioeng (2007) 1.04
Neisserial outer membrane vesicles bind the coinhibitory receptor carcinoembryonic antigen-related cellular adhesion molecule 1 and suppress CD4+ T lymphocyte function. Infect Immun (2007) 1.03
N-myc regulates parkin expression. J Biol Chem (2004) 1.03
Regulation of catecholamines by sustained and intermittent hypoxia in neuroendocrine cells and sympathetic neurons. Hypertension (2003) 1.03
Physical activity and the presence and extent of calcified coronary atherosclerosis. Med Sci Sports Exerc (2002) 1.01
Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users. Neuropharmacology (2008) 1.01
Layer-specific CREB target gene induction in human neocortical epilepsy. J Neurosci (2012) 1.01
Functional association of the parkin gene promoter with idiopathic Parkinson's disease. Hum Mol Genet (2002) 1.00
CEACAM1 (CD66a) promotes human monocyte survival via a phosphatidylinositol 3-kinase- and AKT-dependent pathway. J Biol Chem (2006) 0.99
An aligned 3D neuronal-glial co-culture model for peripheral nerve studies. Biomaterials (2012) 0.99
Moraxella catarrhalis binding to host cellular receptors is mediated by sequence-specific determinants not conserved among all UspA1 protein variants. Infect Immun (2008) 0.99
Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis. Carcinogenesis (2007) 0.99
Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking. Arch Gen Psychiatry (2011) 0.98
Integrated culture and purification of rat Schwann cells from freshly isolated adult tissue. Nat Protoc (2012) 0.98
A yeast 2-hybrid analysis of human GTP cyclohydrolase I protein interactions. J Neurochem (2006) 0.97
Anatomical site influences the differentiation of adipose-derived stem cells for Schwann-cell phenotype and function. Glia (2011) 0.97
Activation of extracellular signal-regulated kinases 1 and 2 by depolarization stimulates tyrosine hydroxylase phosphorylation and dopamine synthesis in rat brain. Eur J Neurosci (2002) 0.97
Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease. Brain (2009) 0.96
Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration. Synapse (2008) 0.96
Mapping human brain fatty acid amide hydrolase activity with PET. J Cereb Blood Flow Metab (2012) 0.93
Operating on a suspicious lung mass without a preoperative tissue diagnosis: pros and cons. Eur J Cardiothorac Surg (2013) 0.93
Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB. Mov Disord (2008) 0.93
Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides. J Invest Dermatol (2002) 0.93
Identification of tyrosine hydroxylase as a physiological substrate for Cdk5. J Neurochem (2004) 0.93
The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients. Neurobiol Aging (2011) 0.93
Validation of the MEDFICTS dietary questionnaire: a clinical tool to assess adherence to American Heart Association dietary fat intake guidelines. Nutr J (2003) 0.92
Brain antioxidant systems in human methamphetamine users. J Neurochem (2004) 0.92
An unusual cause of false-positive results with the BD GeneOhm Cdiff assay. J Clin Microbiol (2013) 0.92
The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer. BMC Cancer (2008) 0.92
Self-organization of skin cells in three-dimensional electrospun polystyrene scaffolds. Tissue Eng (2005) 0.91
Melanoma cell attachment, invasion, and integrin expression is upregulated by tumor necrosis factor alpha and suppressed by alpha melanocyte stimulating hormone. J Invest Dermatol (2002) 0.91
Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2. MAbs (2011) 0.90
All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study. Drug Alcohol Depend (2012) 0.90
New targets of therapy in T-cell lymphomas. Curr Drug Targets (2010) 0.89
Melanocortin signalling mechanisms. Adv Exp Med Biol (2010) 0.88
Dinuclear ruthenium(II) complexes as two-photon, time-resolved emission microscopy probes for cellular DNA. Angew Chem Int Ed Engl (2014) 0.88
Enhancement of tyrosine hydroxylase phosphorylation and activity by glial cell line-derived neurotrophic factor. J Biol Chem (2003) 0.88
Rat retinal dopaminergic neurons: differential maturation of somatodendritic and axonal compartments. J Comp Neurol (2005) 0.88
Development of a bioreactor for evaluating novel nerve conduits. Biotechnol Bioeng (2008) 0.87
Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline. Arch Neurol (2006) 0.87
alpha-Melanocyte stimulating hormone, inflammation and human melanoma. Peptides (2005) 0.87
Acute administration of cocaine regulates the phosphorylation of serine-19, -31 and -40 in tyrosine hydroxylase. J Neurochem (2002) 0.87
Anti-microbial action of melanocortin peptides and identification of a novel X-Pro-D/L-Val sequence in Gram-positive and Gram-negative bacteria. Peptides (2008) 0.87
[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. Mov Disord (2015) 0.86
Does hyperthyroidism increase risk of death due to the ingestion of ecstasy? J Forensic Sci (2007) 0.86
Phosphorylation and activation of tryptophan hydroxylase 2: identification of serine-19 as the substrate site for calcium, calmodulin-dependent protein kinase II. J Neurochem (2007) 0.86
Brain levels of neuropeptides in human chronic methamphetamine users. Neuropharmacology (2007) 0.86
Marked dissociation between high noradrenaline versus low noradrenaline transporter levels in human nucleus accumbens. J Neurochem (2007) 0.85
Development of a closed bioreactor system for culture of tissue-engineered skin at an air-liquid interface. Tissue Eng (2006) 0.85
Laser exposure of gold nanorods can induce intracellular calcium transients. J Biophotonics (2013) 0.85
Sodium salicylate inhibits TNF-alpha-induced NF-kappaB activation, cell migration, invasion and ICAM-1 expression in human melanoma cells. Melanoma Res (2006) 0.84
Laser exposure of gold nanorods can increase neuronal cell outgrowth. Biotechnol Bioeng (2013) 0.84
Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations. Mov Disord (2004) 0.84
alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J Invest Dermatol (2004) 0.83
Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease. Mov Disord (2003) 0.83
Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies. J Cereb Blood Flow Metab (2011) 0.83
GCH1 in early-onset Parkinson's disease. Mov Disord (2009) 0.83
Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans. Synapse (2010) 0.83
Identification of neuronal target genes for CCAAT/enhancer binding proteins. Mol Cell Neurosci (2008) 0.83
Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA). J Forensic Sci (2004) 0.82
Alpha-MSH inhibits inflammatory signalling in Schwann cells. Neuroreport (2004) 0.82
Alpha-melanocyte stimulating hormone cytoprotective biology in human dermal fibroblast cells. Peptides (2005) 0.82